Celsee Joins Bio-Rad
Bio-Rad Laboratories, a global leader of life science research
and clinical diagnostic products has acquired Celsee, Inc.
The Genesis System Achieve Accurate Biological Insight
The Genesis System enables scientists to analyze molecular signatures from hundreds to millions of cells, uniquely allowing the processing of two Slide Technologies for improved results in applications such as single-cell cytometry, single-cell proteogenomics, single-cell transcriptomics, rare-cell enumeration, and immune monitoring. The system provides a practical, scalable, and efficient approach to analyze rare cells. It is open and customizable to support method and application development as well as protocol optimization.
Celsingle™ Slides capture and isolate single cells with a gentle, gravity-based approach. Discrete microwells allow a single cell to be paired with a unique cellular barcode and unique molecular indices for desired applications, such as gene expression or protein quantitation.
Celselect™ Slides capture and isolate individual immune cells, rare cells or CTCs based on their size utilizing microfluidics and 56,400 individual microchambers. Isolated cells can be stained for immunofluorescent applications such as enumeration, FISH, or enriched for downstream methods such as cell-culture or single-cell genomics.
LATEST NEWS & EVENTS
|April 9, 2020||Bio-Rad Acquires Celsee|
|February 13, 2020||Join us at the University of British Columbia for a Seminar on Next-Gen Single-Cell Technology.|
|January 29 – 30||Celsee will be attending the Festival of Genomics 2020.|